A Pilot Study to Evaluate Safety and Efficacy of CigRx™ in Smokers

A Randomized, Double-Blind, Active-Controlled, Crossover, Pilot Study to Evaluate the Safety and Efficacy of CigRx™ Lozenge, a Non-Nicotine Non-Tobacco Dietary Supplement, in Daily Smokers in Temporarily Reducing the Desire to Smoke

A randomized, double-blind, active-controlled, crossover, pilot study to evaluate the safety and efficacy of CigRx™ Lozenge, a dietary supplement, in daily smokers in temporarily reducing the desire to smoke

Subjects will orally self-administer 2 study products, each in the form of a dissolvable lozenge, and will complete questionnaires on demographics, urges to smoke, and product rating.

Inclusion Criteria:

• Healthy adult smokers
• Smoking for at least 5 years
• Smoking at least one (1) pack of cigarettes a day

Exclusion Criteria:

• Allergy to lozenge components